Direct Observation of Treatment Provided by a Family Member as Compared to Non-Family Member among Children with New Tuberculosis: A Pragmatic, Non-Inferiority, Cluster-Randomized Trial in Gujarat, India.

<h4>Background</h4>The World Health Organization recommends direct observation of treatment (DOT) to support patients with tuberculosis (TB) and to ensure treatment completion. As per national programme guidelines in India, a DOT provider can be anyone who is acceptable and accessible to...

Full description

Saved in:
Bibliographic Details
Main Authors: Paresh Vamanrao Dave, Amar Niranjan Shah, Pankaj B Nimavat, Bhavesh B Modi, Kirit R Pujara, Pradip Patel, Keshabhai Mehariya, Kiran Vaman Rade, Soma Shekar, Kuldeep S Sachdeva, John E Oeltmann, Ajay M V Kumar
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0148488
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849332365421182976
author Paresh Vamanrao Dave
Amar Niranjan Shah
Pankaj B Nimavat
Bhavesh B Modi
Kirit R Pujara
Pradip Patel
Keshabhai Mehariya
Kiran Vaman Rade
Soma Shekar
Kuldeep S Sachdeva
John E Oeltmann
Ajay M V Kumar
author_facet Paresh Vamanrao Dave
Amar Niranjan Shah
Pankaj B Nimavat
Bhavesh B Modi
Kirit R Pujara
Pradip Patel
Keshabhai Mehariya
Kiran Vaman Rade
Soma Shekar
Kuldeep S Sachdeva
John E Oeltmann
Ajay M V Kumar
author_sort Paresh Vamanrao Dave
collection DOAJ
description <h4>Background</h4>The World Health Organization recommends direct observation of treatment (DOT) to support patients with tuberculosis (TB) and to ensure treatment completion. As per national programme guidelines in India, a DOT provider can be anyone who is acceptable and accessible to the patient and accountable to the health system, except a family member. This poses challenges among children with TB who may be more comfortable receiving medicines from their parents or family members than from unfamiliar DOT providers. We conducted a non-inferiority trial to assess the effect of family DOT on treatment success rates among children with newly diagnosed TB registered for treatment during June-September 2012.<h4>Methods</h4>We randomly assigned all districts (n = 30) in Gujarat to the intervention (n = 15) or usual-practice group (n = 15). Adult family members in the intervention districts were given the choice to become their child's DOT provider. DOT was provided by a non-family member in the usual-practice districts. Using routinely collected clinic-based TB treatment cards, we compared treatment success rates (cured and treatment completed) between the two groups and the non-inferiority limit was kept at 5%.<h4>Results</h4>Of 624 children with newly diagnosed TB, 359 (58%) were from intervention districts and 265 (42%) were from usual-practice districts. The two groups were similar with respect to baseline characteristics including age, sex, type of TB, and initial body weight. The treatment success rates were 344 (95.8%) and 247 (93.2%) (p = 0.11) among the intervention and usual-practice groups respectively.<h4>Conclusion</h4>DOT provided by a family member is not inferior to DOT provided by a non-family member among new TB cases in children and can attain international targets for treatment success.<h4>Trial registration</h4>Clinical Trials Registry-India, National Institute of Medical Statistics (Indian Council of Medical Research) CTRI/2015/09/006229.
format Article
id doaj-art-ee7f353323144ecc877d5038c2ed300e
institution Kabale University
issn 1932-6203
language English
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-ee7f353323144ecc877d5038c2ed300e2025-08-20T03:46:12ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01112e014848810.1371/journal.pone.0148488Direct Observation of Treatment Provided by a Family Member as Compared to Non-Family Member among Children with New Tuberculosis: A Pragmatic, Non-Inferiority, Cluster-Randomized Trial in Gujarat, India.Paresh Vamanrao DaveAmar Niranjan ShahPankaj B NimavatBhavesh B ModiKirit R PujaraPradip PatelKeshabhai MehariyaKiran Vaman RadeSoma ShekarKuldeep S SachdevaJohn E OeltmannAjay M V Kumar<h4>Background</h4>The World Health Organization recommends direct observation of treatment (DOT) to support patients with tuberculosis (TB) and to ensure treatment completion. As per national programme guidelines in India, a DOT provider can be anyone who is acceptable and accessible to the patient and accountable to the health system, except a family member. This poses challenges among children with TB who may be more comfortable receiving medicines from their parents or family members than from unfamiliar DOT providers. We conducted a non-inferiority trial to assess the effect of family DOT on treatment success rates among children with newly diagnosed TB registered for treatment during June-September 2012.<h4>Methods</h4>We randomly assigned all districts (n = 30) in Gujarat to the intervention (n = 15) or usual-practice group (n = 15). Adult family members in the intervention districts were given the choice to become their child's DOT provider. DOT was provided by a non-family member in the usual-practice districts. Using routinely collected clinic-based TB treatment cards, we compared treatment success rates (cured and treatment completed) between the two groups and the non-inferiority limit was kept at 5%.<h4>Results</h4>Of 624 children with newly diagnosed TB, 359 (58%) were from intervention districts and 265 (42%) were from usual-practice districts. The two groups were similar with respect to baseline characteristics including age, sex, type of TB, and initial body weight. The treatment success rates were 344 (95.8%) and 247 (93.2%) (p = 0.11) among the intervention and usual-practice groups respectively.<h4>Conclusion</h4>DOT provided by a family member is not inferior to DOT provided by a non-family member among new TB cases in children and can attain international targets for treatment success.<h4>Trial registration</h4>Clinical Trials Registry-India, National Institute of Medical Statistics (Indian Council of Medical Research) CTRI/2015/09/006229.https://doi.org/10.1371/journal.pone.0148488
spellingShingle Paresh Vamanrao Dave
Amar Niranjan Shah
Pankaj B Nimavat
Bhavesh B Modi
Kirit R Pujara
Pradip Patel
Keshabhai Mehariya
Kiran Vaman Rade
Soma Shekar
Kuldeep S Sachdeva
John E Oeltmann
Ajay M V Kumar
Direct Observation of Treatment Provided by a Family Member as Compared to Non-Family Member among Children with New Tuberculosis: A Pragmatic, Non-Inferiority, Cluster-Randomized Trial in Gujarat, India.
PLoS ONE
title Direct Observation of Treatment Provided by a Family Member as Compared to Non-Family Member among Children with New Tuberculosis: A Pragmatic, Non-Inferiority, Cluster-Randomized Trial in Gujarat, India.
title_full Direct Observation of Treatment Provided by a Family Member as Compared to Non-Family Member among Children with New Tuberculosis: A Pragmatic, Non-Inferiority, Cluster-Randomized Trial in Gujarat, India.
title_fullStr Direct Observation of Treatment Provided by a Family Member as Compared to Non-Family Member among Children with New Tuberculosis: A Pragmatic, Non-Inferiority, Cluster-Randomized Trial in Gujarat, India.
title_full_unstemmed Direct Observation of Treatment Provided by a Family Member as Compared to Non-Family Member among Children with New Tuberculosis: A Pragmatic, Non-Inferiority, Cluster-Randomized Trial in Gujarat, India.
title_short Direct Observation of Treatment Provided by a Family Member as Compared to Non-Family Member among Children with New Tuberculosis: A Pragmatic, Non-Inferiority, Cluster-Randomized Trial in Gujarat, India.
title_sort direct observation of treatment provided by a family member as compared to non family member among children with new tuberculosis a pragmatic non inferiority cluster randomized trial in gujarat india
url https://doi.org/10.1371/journal.pone.0148488
work_keys_str_mv AT pareshvamanraodave directobservationoftreatmentprovidedbyafamilymemberascomparedtononfamilymemberamongchildrenwithnewtuberculosisapragmaticnoninferiorityclusterrandomizedtrialingujaratindia
AT amarniranjanshah directobservationoftreatmentprovidedbyafamilymemberascomparedtononfamilymemberamongchildrenwithnewtuberculosisapragmaticnoninferiorityclusterrandomizedtrialingujaratindia
AT pankajbnimavat directobservationoftreatmentprovidedbyafamilymemberascomparedtononfamilymemberamongchildrenwithnewtuberculosisapragmaticnoninferiorityclusterrandomizedtrialingujaratindia
AT bhaveshbmodi directobservationoftreatmentprovidedbyafamilymemberascomparedtononfamilymemberamongchildrenwithnewtuberculosisapragmaticnoninferiorityclusterrandomizedtrialingujaratindia
AT kiritrpujara directobservationoftreatmentprovidedbyafamilymemberascomparedtononfamilymemberamongchildrenwithnewtuberculosisapragmaticnoninferiorityclusterrandomizedtrialingujaratindia
AT pradippatel directobservationoftreatmentprovidedbyafamilymemberascomparedtononfamilymemberamongchildrenwithnewtuberculosisapragmaticnoninferiorityclusterrandomizedtrialingujaratindia
AT keshabhaimehariya directobservationoftreatmentprovidedbyafamilymemberascomparedtononfamilymemberamongchildrenwithnewtuberculosisapragmaticnoninferiorityclusterrandomizedtrialingujaratindia
AT kiranvamanrade directobservationoftreatmentprovidedbyafamilymemberascomparedtononfamilymemberamongchildrenwithnewtuberculosisapragmaticnoninferiorityclusterrandomizedtrialingujaratindia
AT somashekar directobservationoftreatmentprovidedbyafamilymemberascomparedtononfamilymemberamongchildrenwithnewtuberculosisapragmaticnoninferiorityclusterrandomizedtrialingujaratindia
AT kuldeepssachdeva directobservationoftreatmentprovidedbyafamilymemberascomparedtononfamilymemberamongchildrenwithnewtuberculosisapragmaticnoninferiorityclusterrandomizedtrialingujaratindia
AT johneoeltmann directobservationoftreatmentprovidedbyafamilymemberascomparedtononfamilymemberamongchildrenwithnewtuberculosisapragmaticnoninferiorityclusterrandomizedtrialingujaratindia
AT ajaymvkumar directobservationoftreatmentprovidedbyafamilymemberascomparedtononfamilymemberamongchildrenwithnewtuberculosisapragmaticnoninferiorityclusterrandomizedtrialingujaratindia